Baudax Bio, Inc. (BXRXQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 6, 2026, 9:30 AM EST
Baudax Bio Revenue
Baudax Bio had revenue of $1.27M in the twelve months ending September 30, 2023, up 217.25% year-over-year. In the year 2022, Baudax Bio had annual revenue of $1.27M with 17.50% growth.
Revenue
1.27M
Revenue Growth
+217.25%
P/S Ratio
0.00
Revenue / Employee
141.00K
Employees
9
Market Cap
5.25K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 1.27M | 189.00K | 17.50% |
| Dec 31, 2021 | 1.08M | 587.00K | 119.07% |
| Dec 31, 2020 | 493.00K | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ONE Bio | 53.91M |
| Kaleido Biosciences | 1.10M |
| MultiCell Technologies | 805.24K |
| Theralink Technologies | 635.45K |
| Syros Pharmaceuticals | 386.00K |
| Athersys | 80.00K |